BioCentury
ARTICLE | Financial News

Cavion raises $26.1M series A

January 6, 2017 11:51 PM UTC

Cavion Inc. (Charlottesville, Va.) raised $26.1 million in a series A round co-led by Lilly Ventures and Novartis Venture Fund. Enso Ventures also participated, as did undisclosed existing investors. The company is developing T-type calcium channel modulators to treat neurology and cancer.

Lilly Ventures' Steven Hall, Novartis Venture Fund's Henry Skinner and Enso's Sergei Petukhov have joined the company’s board...

BCIQ Company Profiles

Cavion Inc.